Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Unicentric, Randomized, Parallel, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy

NCT03851562 is registered in ClinicalTrials.gov with Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia as lead sponsor.

NCT NCT03851562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03851562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Unicentric, Randomized, Parallel, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
Lead sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase
Phase 2
Overall status
Unknown status
Start date
June 13, 2018
Completion date
October 31, 2019
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic optic neuropathy